// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
Generic medicines have benefited millions of Americans and saved trillions of dollars.
Access to medicines is a complicated topic.
In 2015 and 2016, USP launched a series of “roundtable” events designed to engage industry in dis